Loading page…

Nexus Surgical And Medicare Ltd (NEXUSSURGL) · mywealthgrid

About

Nexus Surgical And Medicare Ltd operates in Other Financial Services within the Financials sector.

Face value: ₹10

Market cap

₹17 Cr

P/E

113.2×

P/B

9.6×

Dividend yield

ROE

51.7%

ROCE

69.2%

Debt / equity

OPM

12.2%

EPS (TTM)

₹0.3

Book value

₹3.3

52-week high

₹35.2

52-week low

₹13.3

₹31.5+78.9%1Y

Beta

0.33

Damps index moves

Volatility (1y)

85.5%

Annualised, daily returns

RSI (14)

31.6

Neither overbought nor oversold

Rel. strength (1y)

54%

Ahead of the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+Strong return on equity of 53.2% (3-yr avg)
+High return on capital employed of 71.3%
+Profit CAGR of 37.6% over the last 5 years
+Revenue CAGR of 16% over the last 5 years
+Almost debt-free (debt/equity 0)
+Outperformed the universe by 54% over 1 year

Cons

−Expensive at 113.2× trailing earnings
−Trading at 9.6× book value
−Low promoter holding of 18.7%

Research score

Structured signal from quality, growth, valuation and momentum.

63/100

Business quality: 81
Growth

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	—	0	1	—	—	4	2	2	3	6	8
Interest	—	—	—	—	—	0	0	0	0	0	0
Expenses	0	0	1	2	2	4	2	1	3	5	7
Financing profit	—	—	—	—	—	0	0	0	0	1	1
Financing margin %	—	—	—	—	—	4.3%	15.4%	13.6%	7.5%	11.5%	12.2%
Other income	—	—	0	—	—	0	0	0	0	0	0
Depreciation	—	0	0	0	0	0	0	0	0	0	0
Profit before tax	0	-0	-0	-0	-5	0	0	0	0	1	1
Tax	—	0	—	—	—	0	0	0	0	0	0
Tax %	—	0%	—	—	—	11.8%	25.6%	26.1%	27.6%	25.4%	25.3%
PAT	0	-0	-0	-0	-5	0	0	0	0	1	1
EPS (₹)	—	-0.4	-0.6	-0.2	-9.7	0.3	0.5	0.3	0.4	0.9	1.4
EPS adjusted (₹)	—	—	—	—	—	0.3	0.5	0.3	0.4	0.9	1.4
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	5	5	5	5	5	5
Reserves	-6	-5	-5	-5	-4	-4
Minority interest	—	—	—	0	—	—
	0	0	0	0	0	0
	1	2	1	1	1	2
Total equity & liabilities	1	2	1	2	2	4
	0	0	0	0	0	0
CWIP	—	—	—	—	—	0
Investments	0	0	0	0	0	0
	1	2	1	2	2	4
Total assets	1	2	1	2	2	4

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0	-0	1	-0	0	0
	0	0	-0	0	-0	0
	0	0	0	0	0	0
Net cash flow	0	-0	1	-0	0	0
Free cash flow	0	-0	1	-0	0	0
CFO / Operating profit %	125%	-29.7%	261.9%	-157.7%	15.2%	17.7%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	72.7%	—	71%	82.7%	67.3%	69%
EBITDA margin %	—	—	4.3%	15.4%	13.6%	7.5%	11.5%	12.2%
EBIT margin %	—	—	4.3%	15.4%	13.5%	7.5%	11.5%	12.2%
PAT margin %	—	—	4%	12.1%	11%	6.1%	8.7%	9.4%
Working capital
Receivable days	—	—	12	0	9	79	86	61
Inventory days	—	—	0	77	57	243	84	55
Payable days	—	—	358	320	454	754	230	239
NWC days	—	—	-346	-243	-388	-432	-61	-123
Leverage
Current ratio	—	—	0.78	0.99	1.57	1.41	1.85	1.96
Debt to EBITDA	—	—	0	0	0	0	0	0
Debt to equity	—	—	-0	0	0	0	0	0
Interest coverage	—	—	—	—	—	—	—	—
Asset turnover	—	—	4.02	1.2	1.68	1.92	2.52	2.16
Return ratios
Return on assets %	—	—	16.1%	14.5%	18.5%	11.6%	22%	20.3%
Return on capital employed %	—	—	-154.5%	216.7%	85.2%	62.4%	82.2%	69.2%
Return on equity %	—	—	-136.4%	161.1%	48.6%	37.5%	47.2%	41.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%	18.73%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%	81.27%
No. of shareholders	—	—	—	—	—	—	—	—	6,048	5,997	5,858	5,743

Promoter holding up 0 percentage points since Sep 2023.

26 deals · 19 Apr 2022 – 22 May 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
22 May 2026	RUCHEE CHOTRA	Bulk	BSE	Sell	44,701	₹20.00	₹0.09 Cr
22 May 2026	ACQUITOR FINANCIAL SERVICES PVT.LTD.	Bulk	BSE	Buy	43,726	₹20.00	₹0.09 Cr
20 May 2026	ACQUITOR FINANCIAL SERVICES PVT.LTD.	Bulk	BSE	Buy	40,091	₹19.05	₹0.08 Cr
20 May 2026	MANOJ KUMAR	Bulk	BSE	Sell	39,675	₹19.05	₹0.08 Cr
18 May 2026	RISHABH NEGI	Bulk	BSE	Buy	35,424	₹19.00	₹0.07 Cr
18 May 2026	RUCHEE CHOTRA	Bulk	BSE	Sell	35,299	₹19.00	₹0.07 Cr
25 Sept 2025	LAXMAN SOPAN WAGHMODE	Bulk	BSE	Sell	55,555	₹16.07	₹0.09 Cr
30 Jan 2025	RAJEEV KUMAR SINGH	Bulk	BSE	Sell	42,583	₹14.85	₹0.06 Cr
30 Jan 2025	ACQUITOR FINANCIAL SERVICES PVT.LTD.	Bulk	BSE	Buy	35,000	₹14.72	₹0.05 Cr
27 Nov 2024	HARIVARDHAN STEEL & ALLOYS PRIVATE LIMTED	Bulk	BSE	Buy	34,931	₹19.02	₹0.07 Cr

1–10 of 26

1 / 3

Mr. Ram Swaroop Mahadev JoshiManaging Director
Mr. Pawankumar Sitaram ChoudharyExecutive Director & Chief Financial Officer
Mr. Surya Kant ModiNon - Executive Independent Director
Ms. Neha Kailash BhageriaIndependent Non-Executive Woman Director
Mr. Ashish Durgaprasad MishraNon - Executive Non -Independent Director
Ms. Monika Pawankumar ChoudharyCompany Secretary cum Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Nexus Surgical And Medicare Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results13 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

16 announcementsExport CSV

3 Sept 2026, 4:18 pmCompany Update

Reply On Clarification Sought By Exchange

General PDF

3 Sept 2026, 4:05 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

3 Sept 2026, 4:01 pmAGM/EGM

Notice Of The 35Th Annual General Meeting Of The Company To Be Held On Friday, 25Th September, 2026 At 12:30 P.M. Through Video Conferencing (VC)

AGM PDF

2 Sept 2026, 7:45 pmAGM/EGM

Annual General Meeting To Be Held On Friday, 25Th September, 2026 At 12:30 P.M. Through Video Conferencing (VC)

AGM PDF

2 Sept 2026, 7:10 pmCompany Update

Announcement Under Regulation 30 - Reconstitution Of Committees

General PDF

2 Sept 2026, 7:07 pmCompany Update

Announcement Under Regulation 30 - Reappointment Of Independent Director For A Second Term Of 5 Years

General PDF

2 Sept 2026, 7:05 pmCompany Update

Announcement Under Regulation 30 - Appointment Of Independent Director For A Period Of 5 Years

General PDF

2 Sept 2026, 7:01 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in Directorate PDF

Date	Category	Subject	Filing
3 Sept 2026, 4:18 pm	Company Update General	Reply On Clarification Sought By Exchange	PDF
3 Sept 2026, 4:05 pm	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF

Loading announcements…

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Crisil LimitedCRISILCRISIL	₹32,373 Cr	₹32,373 Cr	₹4,126 Cr	₹1,229 Cr	29.7%	₹884 Cr	21%	33.9%	27.4%	48
RRP Semiconductor LtdRRPRRP	₹11,162 Cr	₹11,168 Cr	₹-7 Cr	₹-7 Cr	—	₹-8 Cr	—	-32.7%	-59.8%	—
Onemi Technology Solutions LimitedKISSHTKISSHT	₹6,254 Cr	₹7,346 Cr	₹2,179 Cr	₹651 Cr	29.9%	₹281 Cr	12.9%	32.9%	21%	-8
Asset Reconstruction Company (India) LimitedARCILARCIL	₹4,546 Cr	₹5,751 Cr	₹722 Cr	₹473 Cr	65.5%	₹-36 Cr	44.7%	—	-1.3%	—
Colab Platforms LtdCOLABCOLAB	₹2,622 Cr	₹2,624 Cr	₹158 Cr	₹2 Cr	1%	₹5 Cr	2.9%	23.2%	17.2%	9
Gyftr LtdGYFTRGYFTR	₹1,204 Cr	₹1,240 Cr	₹14 Cr	₹3 Cr	21.6%	₹2 Cr	12.9%	—	0.5%	—
Prime Securities LimitedPRIMESECUPRIMESECU	₹1,022 Cr	₹1,024 Cr	₹125 Cr	₹13 Cr	15.7%	₹5 Cr	9.6%	—	6.7%	—
Centrum Capital LimitedCENTRUMCENTRUM	₹969 Cr	₹17,026 Cr	₹3,643 Cr	₹948 Cr	29.2%	₹-217 Cr	-7.5%	12.7%	-46.8%	-519
Wealth First Portfolio Managers LimitedWEALTHWEALTH	₹952 Cr	₹952 Cr	₹58 Cr	₹37 Cr	72.3%	₹33 Cr	56%	34.5%	27.7%	563
Stellant Securities (India) LtdSTELLANTSTELLANT	₹518 Cr	₹518 Cr	₹0 Cr	₹-0 Cr	-93.8%	₹-0 Cr	-93.8%	-45.5%	-44.8%	0
The Investment Trust Of India LimitedTHEINVESTTHEINVEST	₹472 Cr	₹523 Cr	₹274 Cr	₹48 Cr	20.2%	₹33 Cr	12.2%	8.5%	4.2%	-42
Ndl Ventures LimitedNDLVENTURENDLVENTURE	₹422 Cr	₹1,328 Cr	₹1,044 Cr	₹149 Cr	17%	₹-38 Cr	0.2%	4.4%	-5.9%	-739

Nexus Surgical And Medicare Ltd

Nexus Surgical And Medicare Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

1

Announcements

Not in the F&O segment

1

No fund holdings on record

Announcements

Annual reports

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

Nexus Surgical And Medicare Ltd

Nexus Surgical And Medicare Ltd

About

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Board meetings1

Announcements

Not in the F&O segment

Board meetings1

Ratio timeline

No fund holdings on record

Announcements

Annual reports

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

1

1